Follicular Lymphoma — Trials

Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 216
Recruiting: 107
Ph III recruiting: 10
Growth YoY: −8.6%
Industry share: 29%
Top sponsor: City of Hope Medical Center
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (149)

clinicaltrialsPublishedShowing 51–100 of 129 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04587687	Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma	recruiting	Phase 2	23	University of California, DavisOTHER	1	Jun 29, 2026	clinicaltrials
NCT03314974	Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders	recruiting	Phase 2	300	Masonic Cancer Center, University of MinnesotaOTHER	1	Jun 25, 2026	clinicaltrials